科学图书馆
-
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"JG Howlett. -
SPECT and PET in ischemic heart failureAngelidis G, Giamouzis G, Karagiannis G et al.
-
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes MellitusK Ejiri, T Miyoshi, MUSCAT‐HF Study Investigators.
-
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart FailureCK Nagaraju, EL Robinson, KR Sipido et al.
-
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection FractionBeale AL, Meyer P, Kaye DM et al.
-
Titration of Medical Therapy for Heart Failure With Reduced Ejection FractionSJ Greene, GC Fonarow, AD DeVore et al.
-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart FailureMehra MR, Goldstein DJ, MOMENTUM 3 Investigators.
-
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)DP Leong, JJV McMurray, PG Joseph et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
